A prospective, randomized placebo-controlled multicenter trial evaluating fenoldopam mesylate for the prevention of contrast induced nephropathy: The CONTRAST trial

✍ Scribed by Gregg W. Stone; Peter McCullough; James Tumlin; Hooman Madyoon; Patrick Murray; Andrew Wang; A. Alan Chu; Gary Schaer; Melissa Stevens; Robert L. Wilensky; William W. O'Neill; Norman Lepor

• Book ID: 119546498
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 310 KB
• Volume: 41
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/s0735-1097(03)80973-7